ZYVERSA THERAPEUTICS, INC. Other Operating Income (Expense), Net
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Other Operating Income (Expense), Net of $354.07 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2022-11-14
- ZYVERSA THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2022-09-30 was $354.07K.
- ZYVERSA THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2022-06-30 was $105.11K.
- ZYVERSA THERAPEUTICS, INC. other operating income (expense), net for the quarter ending 2022-03-31 was $81.04K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month |
|---|---|---|---|
| 2022-09-30 | $354.07K 10-Q · filed 2022-11-14 | $459.18K derived: sum of 2 quarters · filed 2022-11-14 | $540.22K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $105.11K 10-Q · filed 2022-08-15 | $186.16K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $81.04K 10-Q · filed 2022-05-13 | ||
| 2021-12-31 | -$5.43K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |